In Southern Africa, HIV affects women and young girls disproportionately. Women account for 56% of infections and 12,6% of the population is HIV positive. AIDS-related illnesses are the leading cause of death for women aged 15 to 44 years and young girls between the ages of 15 and 24 years accounted for 44% of new infections in 2017 — even though they make up 10% of the population in the region, according to the HIV education organisation Avert.
However, there is hope. The world is closer than ever in the ongoing quest to #makeHIVhistory.
It has been a year since Johnson & Johnson together with its partners launched the study to evaluate a new HIV vaccine in development at its Janssen Pharmaceutical Companies.
And it feels like we’re closer to a vaccine than ever before! Share the stories of the researchers working on the front lines to end HIV once and for all.